This study provides robust evidence supporting the use of SGLT2 inhibitors in heart failure with preserved ejection fraction. Long-term outcomes data would further strengthen these findings. – https://www.bienne2go.ch/en/Z15151/city-biel-bienne?l=0 , Comprehensive update on multiple sclerosis disease-modifying therapies. Personalized treatment algorithms are the future. .
Your review is awaiting approval
This study provides robust evidence supporting the use of SGLT2 inhibitors in heart failure with preserved ejection fraction. Long-term outcomes data would further strengthen these findings. – https://www.bienne2go.ch/en/Z15151/city-biel-bienne?l=0 , Comprehensive update on multiple sclerosis disease-modifying therapies. Personalized treatment algorithms are the future. .